173 related articles for article (PubMed ID: 35935409)
41. Attitude toward antipsychotic medication as a predictor of antipsychotic treatment discontinuation in first-episode early-onset psychosis.
Fraguas D; Llorente C; Rapado-Castro M; Parellada M; Moreno D; Ruiz-Sancho A; Medina O; Alvarez-Segura M; de Castro MJ; Arango C
Rev Psiquiatr Salud Ment; 2008 Dec; 1(1):10-7. PubMed ID: 23040428
[TBL] [Abstract][Full Text] [Related]
42. Withdrawal versus continuation of chronic antipsychotic drugs for behavioural and psychological symptoms in older people with dementia.
Declercq T; Petrovic M; Azermai M; Vander Stichele R; De Sutter AI; van Driel ML; Christiaens T
Cochrane Database Syst Rev; 2013 Mar; (3):CD007726. PubMed ID: 23543555
[TBL] [Abstract][Full Text] [Related]
43. Financial incentives for improving adherence to maintenance treatment in patients with psychotic disorders (Money for Medication): a multicentre, open-label, randomised controlled trial.
Noordraven EL; Wierdsma AI; Blanken P; Bloemendaal AF; Staring AB; Mulder CL
Lancet Psychiatry; 2017 Mar; 4(3):199-207. PubMed ID: 28236956
[TBL] [Abstract][Full Text] [Related]
44. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment.
Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G
Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074
[TBL] [Abstract][Full Text] [Related]
45. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
[TBL] [Abstract][Full Text] [Related]
46. Predictors of treatment discontinuation and medication nonadherence in patients recovering from a first episode of schizophrenia, schizophreniform disorder, or schizoaffective disorder: a randomized, double-blind, flexible-dose, multicenter study.
Perkins DO; Gu H; Weiden PJ; McEvoy JP; Hamer RM; Lieberman JA;
J Clin Psychiatry; 2008 Jan; 69(1):106-13. PubMed ID: 18312044
[TBL] [Abstract][Full Text] [Related]
47. Mood-stabilizer-maintained, remitted bipolar patients: taper and discontinuation of adjunctive antipsychotic medication.
Saksa JR; Baker CB; Woods SW
Gen Hosp Psychiatry; 2004; 26(3):233-6. PubMed ID: 15121352
[TBL] [Abstract][Full Text] [Related]
48. Perspective on medication decisions following remission from first-episode psychosis.
Hui CLM; Lam BST; Lee EHM; Chan SKW; Chang WC; Suen YN; Chen EYH
Schizophr Res; 2020 Nov; 225():82-89. PubMed ID: 32115314
[TBL] [Abstract][Full Text] [Related]
49. Second-generation antipsychotic discontinuation in first episode psychosis: an updated review.
Miller BJ; Bodenheimer C; Crittenden K
Clin Psychopharmacol Neurosci; 2011 Aug; 9(2):45-53. PubMed ID: 23429653
[TBL] [Abstract][Full Text] [Related]
50. The efficacy, acceptability, and safety of five atypical antipsychotics in patients with first-episode drug-naïve schizophrenia: a randomized comparative trial.
Wang C; Shi W; Huang C; Zhu J; Huang W; Chen G
Ann Gen Psychiatry; 2017; 16():47. PubMed ID: 29299043
[TBL] [Abstract][Full Text] [Related]
51. Effectiveness of Antipsychotic Drugs for 24-Month Maintenance Treatment in First-Episode Schizophrenia: Evidence From a Community-Based "Real-World" Study.
Zhang C; Chen MJ; Wu GJ; Wang ZW; Rao SZ; Zhang Y; Yi ZH; Yang WM; Gao KM; Song LS
J Clin Psychiatry; 2016 Nov; 77(11):e1460-e1466. PubMed ID: 28076667
[TBL] [Abstract][Full Text] [Related]
52. Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes.
Omachi Y; Sumiyoshi T
Front Psychiatry; 2018; 9():447. PubMed ID: 30294286
[No Abstract] [Full Text] [Related]
53. Staged treatment and acceptability guidelines in early psychosis study (STAGES): A randomized placebo controlled trial of intensive psychosocial treatment plus or minus antipsychotic medication for first-episode psychosis with low-risk of self-harm or aggression. Study protocol and baseline characteristics of participants.
O'Donoghue B; Francey SM; Nelson B; Ratheesh A; Allott K; Graham J; Baldwin L; Alvarez-Jimenez M; Thompson A; Fornito A; Polari A; Berk M; Macneil C; Crisp K; Pantelis C; Yuen HP; Harrigan S; McGorry P
Early Interv Psychiatry; 2019 Aug; 13(4):953-960. PubMed ID: 30024100
[TBL] [Abstract][Full Text] [Related]
54. Residual Effect of Texting to Promote Medication Adherence for Villagers with Schizophrenia in China: 18-Month Follow-up Survey After the Randomized Controlled Trial Discontinuation.
Cai Y; Gong W; He W; He H; Hughes JP; Simoni J; Xiao S; Gloyd S; Lin M; Deng X; Liang Z; Dai B; Liao J; Hao Y; Xu DR
JMIR Mhealth Uhealth; 2022 Apr; 10(4):e33628. PubMed ID: 35438649
[TBL] [Abstract][Full Text] [Related]
55. Discontinuation and remission rates and social functioning in patients with schizophrenia receiving second-generation antipsychotics: 52-week evaluation of JUMPs, a randomized, open-label study.
Ishigooka J; Nakagome K; Ohmori T; Iwata N; Inada K; Iga JI; Kishi T; Fujita K; Kikuchi Y; Shichijo T; Tabuse H; Koretsune S; Terada H; Terada H; Kishimoto T; Tsutsumi Y; Kanda Y; Ohi K; Sekiyama K
Psychiatry Clin Neurosci; 2022 Jan; 76(1):22-31. PubMed ID: 34626144
[TBL] [Abstract][Full Text] [Related]
56. Maintenance treatment for patients with a first psychotic episode.
Sommer IEC; Oomen PP; Hasan A
Curr Opin Psychiatry; 2019 May; 32(3):147-156. PubMed ID: 30720486
[TBL] [Abstract][Full Text] [Related]
57. Risk of symptom recurrence with medication discontinuation in first-episode psychosis: a systematic review.
Zipursky RB; Menezes NM; Streiner DL
Schizophr Res; 2014 Feb; 152(2-3):408-14. PubMed ID: 23972821
[TBL] [Abstract][Full Text] [Related]
58. Stability and development of psychotic symptoms and the use of antipsychotic medication - long-term follow-up.
Gotfredsen DR; Wils RS; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AAE; Mors O; Nordentoft M
Psychol Med; 2017 Sep; 47(12):2118-2129. PubMed ID: 28382874
[TBL] [Abstract][Full Text] [Related]
59. Psychiatrists' opinion towards medication discontinuation in remitted first-episode psychosis: A multi-site study of the Asian Network for Early Psychosis.
Hui CL; Wong AK; Leung WW; Lee EH; Chan SK; Chang WC; Chen EY; Chan TC; Swapna V; Tagata H; Tsujino N; Nemoto T; Mizuno M; Kang NI; Kim SW; Chung YC
Early Interv Psychiatry; 2019 Dec; 13(6):1329-1337. PubMed ID: 30485671
[TBL] [Abstract][Full Text] [Related]
60. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials.
Højlund M; Kemp AF; Haddad PM; Neill JC; Correll CU
Lancet Psychiatry; 2021 Jun; 8(6):471-486. PubMed ID: 34023019
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
